Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging.
about
Magnetic resonance imaging in psoriatic arthritis: a review of the literatureEfficacy of infliximab on MRI-determined bone oedema in psoriatic arthritisAnkylosing spondylitis: an overviewTherapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approachesEnthesopathies and enthesitis. Part 2: Imaging studiesOld and new treatment targets in axial spondyloarthritisChange in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulationTreatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiencesNew treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy.Treatment trials in ankylosing spondylitis: current and future considerations.Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides.Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systemsDouble blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis.Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response.Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitisLow grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up.Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral boneInfliximab for the treatment of ankylosing spondylitis.Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides.Vertebral body corner oedema vs gadolinium enhancement as biomarkers of active spinal inflammation in ankylosing spondylitis.Simultaneous Quantification of Bone Edema/Adiposity and Structure in Inflamed Bone Using Chemical Shift-Encoded MRI in Spondyloarthritis.Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies.Severe bone marrow edema on sacroiliac joint MRI increases the risk of low BMD in patients with axial spondyloarthritisThe efficacy and safety of rituximab in a patient with rheumatoid spondylitis.Imaging in rheumatology: reconciling radiology and rheumatology.Progress in spondylarthritis. Spondyloarthritis: lessons from imagingAnti-TNF-alpha therapy with infliximab in spondyloarthritides.The impact of MRI on the clinical management of inflammatory arthritides.Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature.Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspectiveOsteoimmunology and bone homeostasis: relevance to spondyloarthritis.Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23.Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients.Anti-TNF agents for the treatment of spondyloarthropathies.
P2860
Q22000866-EC8D1019-9B9C-4F33-B0DF-908BA221E4D4Q24674877-71EE2014-6435-458D-9CB6-0BDFB3561AFBQ24675044-E8BBACAF-C891-46D2-91AC-C0B1EF10CF65Q24806367-57108E71-E337-4598-8F14-57B6307F686FQ26775660-9842CCBD-F37B-4B7B-828E-C04E9A9FB75EQ26777906-4C2110E9-5FD5-41F3-98AE-2771C6F7FAA4Q33390403-F63C55BF-17E6-4C35-B3D8-F85D3BDC14EEQ33923744-ADDF2A79-C51E-421C-92E8-710553B10595Q34071316-B379682C-9FDC-49E9-A910-1EF056725E89Q34560574-C48A44B5-6B00-49AF-A111-87ECE6058FD6Q34967507-73A7AA0A-E068-4344-ACAE-F327D6A55C3AQ35164736-E288DD9B-BF5A-4C13-8D2F-734B2AC4AD92Q35554475-F4045841-EF61-40B8-BCC4-6EEF8B1A7214Q35555116-3D255218-A648-4570-86DF-196A46154313Q35555515-822F9444-D547-44A3-9394-41A6544D59E0Q35585432-C7F7492D-E679-4699-9ACC-A499F9D140B0Q35605658-9B47B832-D5F4-4941-AE98-15EB9E36DB9FQ35637051-99DC2A7C-58A7-4E93-B0CC-97E168944F8BQ35637293-E999D5C6-BAED-4328-960E-0086C486FF75Q36171850-A6FCCAB2-1F19-45DD-B03B-EC5463B8EBA8Q36210882-FC08491B-7F68-4447-9A33-8DCC11AA9CDAQ36245711-E75481A4-0FD0-4932-8D2B-FCBFDB9EACEDQ36365524-3D5BE592-BC16-47D3-BAFB-986B5809D2E0Q36394657-7D884642-F5F5-46B1-85A6-39CC7DFBA09FQ36577527-E62F6F95-EE11-4D05-BCCC-71B127617D61Q36638774-F614C5DB-C2DA-44A3-8AF6-78BF9D4C600CQ37353874-E6385A82-E2F8-4151-9FCB-9976DB60EB66Q37356387-BE2A92E2-8C09-424A-9118-E88B222D3559Q37516572-194D7D52-23A4-423A-8914-B3C0A38DA69DQ37729028-53895821-6B82-44F8-B792-5CF7262CC8EBQ37918963-A8BD2E26-1CDA-48A0-81D8-BE2A6617A813Q38014263-33A47467-5F4D-4AB2-9002-82A81C8413D2Q38068578-2E7CC2CF-98E5-49F9-92EE-5B51E0B4F77EQ38070027-3BDFC060-6F49-41F8-AA0B-A8F9AB724C70Q38109578-CA0A3A81-187A-4584-AD10-0AF5BEDB1A9DQ38593977-FCDCEEC4-883A-49DB-839F-94B7AB9D2B28Q39185886-7261B4D3-2C78-481D-ACFD-5C595BBF948BQ39874212-F0763E33-CC8D-4B4A-8907-ED18B1BC643FQ40204477-12808158-EDC0-4A4E-AC49-D5BF4741AA61Q40409369-B5DB0232-26E5-4A0E-9566-38B355B1CC9E
P2860
Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Quantitative analyses of sacro ...... by magnetic resonance imaging.
@ast
Quantitative analyses of sacro ...... by magnetic resonance imaging.
@en
type
label
Quantitative analyses of sacro ...... by magnetic resonance imaging.
@ast
Quantitative analyses of sacro ...... by magnetic resonance imaging.
@en
prefLabel
Quantitative analyses of sacro ...... by magnetic resonance imaging.
@ast
Quantitative analyses of sacro ...... by magnetic resonance imaging.
@en
P2093
P2860
P356
P1476
Quantitative analyses of sacro ...... by magnetic resonance imaging.
@en
P2093
Backhaus M
Reisshauer H
P2860
P304
P356
10.1136/ARD.59.2.135
P407
P577
2000-02-01T00:00:00Z